Peer Review History

Original SubmissionMarch 11, 2025
Decision Letter - PUGAZHENTHAN THANGARAJU, Editor

Dear Dr. guanghui,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jun 19 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

PUGAZHENTHAN THANGARAJU, M.D.,Ph.D., FRCP (LONDON)., FRCP (GLASGOW).,MBA.,

Academic Editor

PLOS ONE

Journal requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

3. Please amend the manuscript submission data (via Edit Submission) to include author Peng Liu.

4. We note that Figure 1A, 1B in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

1. You may seek permission from the original copyright holder of Figure 1A, 1B to publish the content specifically under the CC BY 4.0 license. 

We recommend that you contact the original copyright holder with the Content Permission Form (http://journals.plos.org/plosone/s/file?id=7c09/content-permission-form.pdf) and the following text:

“I request permission for the open-access journal PLOS ONE to publish XXX under the Creative Commons Attribution License (CCAL) CC BY 4.0 (http://creativecommons.org/licenses/by/4.0/). Please be aware that this license allows unrestricted use and distribution, even commercially, by third parties. Please reply and provide explicit written permission to publish XXX under a CC BY license and complete the attached form.”

Please upload the completed Content Permission Form or other proof of granted permissions as an "Other" file with your submission.

In the figure caption of the copyrighted figure, please include the following text: “Reprinted from [ref] under a CC BY license, with permission from [name of publisher], original copyright [original copyright year].”

2. If you are unable to obtain permission from the original copyright holder to publish these figures under the CC BY 4.0 license or if the copyright holder’s requirements are incompatible with the CC BY 4.0 license, please either i) remove the figure or ii) supply a replacement figure that complies with the CC BY 4.0 license. Please check copyright information on all replacement figures and update the figure caption with source information. If applicable, please specify in the figure caption text when a figure is similar but not identical to the original image and is therefore for illustrative purposes only.

The following resources for replacing copyrighted map figures may be helpful:

USGS National Map Viewer (public domain): http://viewer.nationalmap.gov/viewer/

The Gateway to Astronaut Photography of Earth (public domain): http://eol.jsc.nasa.gov/sseop/clickmap/

Maps at the CIA (public domain): https://www.cia.gov/library/publications/the-world-factbook/index.html and https://www.cia.gov/library/publications/cia-maps-publications/index.html

NASA Earth Observatory (public domain): http://earthobservatory.nasa.gov/

Landsat: http://landsat.visibleearth.nasa.gov/

USGS EROS (Earth Resources Observatory and Science (EROS) Center) (public domain): http://eros.usgs.gov/#

Natural Earth (public domain): http://www.naturalearthdata.com/

5. Please include a copy of Table 1 and 2 which you refer to in your text on page 33.

6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information .

7. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Yes

Reviewer #2: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: No

**********

Reviewer #1: The study is scientifically sound and methodologically robust. However, specific revisions are needed to enhance clarity, strengthen methodological transparency, and improve practical utility. Below are detailed suggestions:

1. Enhance Methodological Transparency:

Provide more detail on the BAPC model, including its assumptions, validation specific to AA data, and any sensitivity analyses performed to support the 2050 projections. This could be added to the Methods section (e.g., 1–2 paragraphs).

Include uncertainty estimates (e.g., 95% CIs) for the decomposition analysis results to quantify the precision of aging, population growth, and epidemiological contributions.

2. Address Confounding and Context:

Discuss potential confounders (e.g., advances in AA screening, surgical techniques, or hypertension treatment) that may explain the declining ASMR/ASDR in high-SDI regions. This could be a paragraph in the Discussion.

Briefly acknowledge other AA risk factors (e.g., smoking, genetics) and clarify why the study focuses solely on hypertension, perhaps in the Introduction or Discussion, to justify its scope.

3. Strengthen Clinical and Policy Implications:

Expand the Conclusion or add a subsection in the Discussion to propose specific, evidence-based interventions (e.g., hypertension screening programs, blood pressure control policies) tailored to high-burden regions (e.g., low-middle SDI countries, males, elderly). This would enhance the study’s practical impact.

Reviewer #2: 1. Clarity is needed on how the GBD methodology distinguishes hypertensive contributions from other overlapping risk factors (e.g., smoking, dyslipidemia). Explain how hypertension-specific burden was isolated from the overall AA burden.

2. The BAPC model is a strength, but its assumptions and limitations should be more explicitly described. Were sensitivity analyses performed to validate predictions to 2050? Please explain why the model was chosen over alternatives like Joinpoint regression or ARIMA.

3. Several sentences are grammatically not good or overly long. For example:

“The disease burden is particularly severe in regions with low to middle social demographic indices (SDI), among males, and in the elderly population.”

Consider professional English language editing for overall readability.

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org

Revision 1

Dear editors and reviewers:

Thank you for your comments concerning our manuscript entitled “The global burden of Aortic Aneurysm attributable to Hypertension from 1990 to 2021: Current Trends and Projections for 2050”. Those comments are all valuable and very helpful for revising and improving our paper. We have studied the comments carefully and have made corrections which we hope meet with approval. The main revisions to the paper and our responses to the comments are provided below.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

Response:

Thank you very much for your valuable suggestions. We have revised our manuscript according to the formatting requirements of PLOS ONE . At the same time, we have also updated the manuscript and file names according to the guidelines of the journal.

2.PLOS requires an ORCID iD for the corresponding author in Editorial Manager on papers submitted after December 6th, 2016. Please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field. This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

Response:

Thank you very much for your valuable suggestions. Our corresponding author has registered for an ORCID iD and has completed the association and verification in the editorial management system as per your instructions.

3.Please amend the manuscript submission data (via Edit Submission) to include author Peng Liu.

Response:

Thank you very much for your valuable suggestions. We have updated the list of authors in the submission system to include Peng Liu.

4.We note that Figure 1A, 1B in your submission contain [map/satellite] images which may be copyrighted. All PLOS content is published under the Creative Commons Attribution License (CC BY 4.0), which means that the manuscript, images, and Supporting Information files will be freely available online, and any third party is permitted to access, download, copy, distribute, and use these materials in any way, even commercially, with proper attribution. For these reasons, we cannot publish previously copyrighted maps or satellite images created using proprietary data, such as Google software (Google Maps, Street View, and Earth). For more information, see our copyright guidelines: http://journals.plos.org/plosone/s/licenses-and-copyright.

We require you to either (1) present written permission from the copyright holder to publish these figures specifically under the CC BY 4.0 license, or (2) remove the figures from your submission:

Response:

Thank you very much for your valuable suggestions. The map images used in the article were created with the rnaturalearth R package, which accesses open-source map data from Natural Earth (https://github.com/ropensci/rnaturalearth). According to our understanding and information provided by Natural Earth, this map data is in the public domain and is specifically intended for open, unrestricted use. Therefore, we believe no additional copyright permission is required for publication. If necessary, we are happy to include a statement in the figure legends attributing Natural Earth as the data source.

5.Please include a copy of Table 1 and 2 which you refer to in your text on page 33.

Response:

Thank you very much for your valuable suggestions. As per your request, we have incorporated Table 1 and Table 2, which were referenced on page 33 of the original manuscript, into the main text.

6. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information:http://journals.plos.org/plosone/s/supporting-information.Response:

Thank you very much for your valuable suggestions. We have added legends for the supporting information files at the end of the manuscript. The main text has also been updated to ensure that all references to the supporting information are clear and accurate.

7. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Response:

Thank you very much for your valuable suggestions. We have carefully reviewed the reference list to ensure its accuracy and completeness. As we have supplemented the content of the manuscript, there are newly added references in the sections highlighted in blue, which has resulted in changes to the original reference numbering. In addition, we have replaced the retracted articles with more recent references.

Thank you again for your thorough review and valuable suggestions, which will help us further improve the quality of our manuscript.

Reviewer 1

1. Enhance Methodological Transparency:

Provide more detail on the BAPC model, including its assumptions, validation specific to AA data, and any sensitivity analyses performed to support the 2050 projections. This could be added to the Methods section (e.g., 1–2 paragraphs).

Include uncertainty estimates (e.g., 95% CIs) for the decomposition analysis results to quantify the precision of aging, population growth, and epidemiological contributions.

Response:

First of all, we sincerely thank you for your valuable comments. According to your suggestions, we have revised the Methods section to provide more detailed information about the Bayesian age-period-cohort (BAPC) modeling framework. Specifically, we now clearly state that the BAPC model treats age, period, and cohort effects as second-order random walks, assumes that the disability-adjusted life years (DALY) rates follow a Poisson distribution, and uses the integrated nested Laplace approximation (INLA) for inference. We have also described the model validation approach, i.e., evaluating predictive accuracy by comparing predicted and observed DALY rates within a withheld historical time window. The results indicated high predictive accuracy for our dataset (see the Methods section, page 8, highlighted in blue).

In addition, as per your suggestion, we explicitly acknowledge that due to limited resources, we did not conduct formal sensitivity analyses (such as changing the model fitting time window or prior distributions), and this has now been listed as a limitation of the study. We agree on the importance of evaluating the robustness of the predictions and suggest that future studies conduct comprehensive sensitivity analyses under alternative modeling assumptions.

Regarding your second suggestion, we acknowledge that using methods to estimate 95% confidence intervals can provide valuable uncertainty estimates for the decomposition analysis, thereby quantifying the precision of the contributions from aging, population growth, and epidemiological changes. However, our software utilizes a deterministic analysis approach, which may lead to results that differ slightly from those obtained using statistical resampling methods. Nevertheless, this deterministic method allows for a direct and transparent quantification of each factor’s contribution, and is computationally efficient and feasible, facilitating clear interpretation.

The primary aim of our study was to establish a clear and easily interpretable deterministic decomposition framework. We greatly appreciate your valuable suggestion, and in future work, we plan to further explore methods for uncertainty analysis to enhance the robustness and rigor of our findings.

Thank you once again for your insightful comments!

2. Address Confounding and Context:

Discuss potential confounders (e.g., advances in AA screening, surgical techniques, or hypertension treatment) that may explain the declining ASMR/ASDR in high-SDI regions. This could be a paragraph in the Discussion.

Briefly acknowledge other AA risk factors (e.g., smoking, genetics) and clarify why the study focuses solely on hypertension, perhaps in the Introduction or Discussion, to justify its scope.

Response:

Thank you very much for your valuable suggestions. In response, we have revised the Discussion section to clearly outline several confounding factors, such as advances in AA screening programs in regions with higher SDI, improvements in surgical techniques, and comprehensive hypertension management systems. We noted that broader screening facilitates earlier detection and intervention, advanced surgical techniques can improve patient survival rates, and better hypertension management can mitigate the burden of aortic aneurysm. As our study could not directly control for these factors, we now explicitly acknowledge them as important confounders that may contribute to the observed reduction in disease burden in regions with higher SDI (see the Discussion section, pages 25–26, highlighted in blue).

Additionally, we have added a brief explanation to the Introduction section. Although multiple risk factors such as smoking, genetics, and age are associated with aortic aneurysm mortality, we focused our analysis on hypertension due to its high prevalence and modifiable nature. We recognize this as an innovative aspect of our study and suggest that future research on aortic aneurysm control can be initiated from the perspective of hypertension as a key risk factor (see the Introduction section, pages4-5, highlighted in blue).

3.Strengthen Clinical and Policy Implications:

Expand the Conclusion or add a subsection in the Discussion to propose specific, evidence-based interventions (e.g., hypertension screening programs, blood pressure control policies) tailored to high-burden regions (e.g., low-middle SDI countries, males, elderly). This would enhance the study’s practical impact.

Response:

Thank you for your valuable suggestions. In accordance with your advice, we have added content to the last paragraph of the Discussion section, proposing specific evidence-based interventions for regions and populations with a high burden of aortic aneurysm, particularly in countries with low and middle sociodemographic index, as well as among males and the elderly. (See the Discussion section, page 30, highlighted in blue.)

Reviewer 2

1.Clarity is needed on how the GBD methodology distinguishes hypertensive contributions from other overlapping risk factors (e.g., smoking, dyslipidemia). Explain how hypertension-specific burden was isolated from the overall AA burden.

Response:

Thank you for your valuable suggestions. In response, we have revised the Methods section to clarify that the GBD study estimates the burden attributable to hypertension based on the theoretical minimum risk exposure level, using population attributable fractions (PAFs). Importantly, when multiple risk factors (such as smoking, dyslipidemia, and hypertension) coexist, the GBD employs a joint attribution algorithm based on a multiplicative model. This approach distributes the overall disease burden across all risk factors, avoids double counting, and ensures that the contribution of each risk factor can be assessed independently.

Therefore, in our study, the burden attributable to hypertension specifically reflects the proportion of aortic aneurysm burden caused by elevated blood pressure alone, rather than by other risk factors. We have explicitly clarified this point in the revised manuscript to enhance transparency. We sincerely thank the reviewer for prompting this important clarification (see the Methods section, pages 6–7, highlighted in blue).

2. The BAPC model is a strength, but its assumptions and limitations should be more explicitly described. Were sensitivity analyses performed to validate predictions to 2050? Please explain why the model was chosen over alternatives like Joinpoint regression or ARIMA.

Response:

Thank you to the reviewer for your valuable suggestions. In response, we have revised the Methods section to provide detailed explanations of the key aspects of the BAPC method. Specifically, we clarified that age, period, and cohort effects were modeled as second-order random walks; that the observed disability-adjusted life year (DALY) rates were assumed to follow a Poisson distribution; and that inference was conducted using the integrated nested Laplace approximation (INLA) method. We now explicitly state that all available annual data from 1990 to 2021 were used for model fitting, with default prior settings adopted to generate forecasts up to the year 2050.

For model validation, we reserved part of the data for evaluation, comparing predicted and observed DALY rates within a historical time window, and found that the model demonstrated high predictive accuracy. However, due to practical limitations, we did not conduct formal sensitivity analyses, such as varying the fitting time window or prior assumptions. This limitation has now been acknowledged as a study weakness, and we recommend that future studies undertake robust sensitivity analyses to evaluate the stability of the predictions.

Regarding model selection, compared to alternative models such as Joinpoint regression or autoregressive integrated moving average (ARIMA) models, we chose the BAPC approach because it explicitly accounts for age, period, and cohort effects, allowing for a more flexible and comprehensive assessment of temporal trends. This is essential for the long-term disease burden projections required in our study. We have incorporated these details into the revised manuscript to enhance the transparency and rationale of our modeling methodology.

3.Several sentences are grammatically not good or overly long. For example:

“The disease burden is particularly severe in regions with low to middle social demographic indices (SDI), among males, and in the elderly population.”

Consider professional English language editing for overall readability.

Response:

Thank you for your valuable suggestions regarding the language and readability of our manuscript. In response to your comments, we carefully reviewed the entire text and revised numerous sentences to improve clarity, conciseness, and grammatical accuracy. We shortened overly long sentences and corrected grammatical errors to enhance the overall readability of the manuscript.

Finally, I would like to once again express my sincere gratitude to the editor and reviewers for their valuable comments and suggestions.

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - PUGAZHENTHAN THANGARAJU, Editor

The global burden of Aortic Aneurysm attributable to Hypertension from 1990 to 2021: Current Trends and Projections for 2050

PONE-D-25-12824R1

Dear Dr. liu,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

PUGAZHENTHAN THANGARAJU, M.D.,Ph.D., FRCP (LONDON)., FRCP (GLASGOW).,MBA.,

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Formally Accepted
Acceptance Letter - PUGAZHENTHAN THANGARAJU, Editor

PONE-D-25-12824R1

PLOS ONE

Dear Dr. liu,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

DR. PUGAZHENTHAN THANGARAJU

Academic Editor

PLOS ONE

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .